HeMemics Biotechnologies Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $100K
Latest Deal Amount
  • Investors
  • 5

HeMemics Biotechnologies General Information

Description

Developer of a cell preservation platform designed to dehydrate biologics in dried or partially dried format for wider distribution and ease of use. The company's platform helps in preserving of mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature instead of frozen format, enabling medical practitioners to stabilize biologics in a dried or partially dried format for less damage to proteins or cells, ease of storage, transport and extended shelf-life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
  • 401 Professional Drive
  • Suite 220
  • Gaithersburg, MD 20879-3445
  • United States
+1 (240) 000-0000

HeMemics Biotechnologies Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HeMemics Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 14-Dec-2020 $100K 00.000 Completed Generating Revenue
7. Secondary Transaction - Private 00.000 Completed Generating Revenue
6. Seed Round 11-Dec-2019 00.00 00.000 00.00 Completed Generating Revenue
5. Angel (individual) 25-May-2018 00000 00000 Completed Startup
4. Seed Round 18-Dec-2017 00000 00000 00.000 Completed Startup
3. Accelerator/Incubator 01-Dec-2017 00000 Completed Startup
2. Grant 01-Jan-2012 $185K $107K Completed Startup
1. Accelerator/Incubator 13-Aug-2007 $107K $107K Completed Startup
To view HeMemics Biotechnologies’s complete valuation and funding history, request access »

HeMemics Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
To view HeMemics Biotechnologies’s complete cap table history, request access »

HeMemics Biotechnologies Executive Team (8)

Name Title Board Seat Contact Info
John Warden Jr. Co-Founder, Chief Executive Officer, Chief Operating Officer & Board Member
David Ho Ph.D Co-Founder, Chief Scientific Officer & Board Member
Bruce Campbell Executive Officer & Board Member
James Hogarty Executive Officer & Board Member
Roger Brook Executive Officer & Board Member
You’re viewing 5 of 8 executive team members. Get the full list »

HeMemics Biotechnologies Board Members (12)

Name Representing Role Since
Bruce Campbell HeMemics Biotechnologies Executive Officer & Board Member 000 0000
David Ho Ph.D HeMemics Biotechnologies Co-Founder, Chief Scientific Officer & Board Member 000 0000
Hao Nguyen Ph.D Self Board Member 000 0000
Hao Nguyen Self Board Member 000 0000
James Hogarty HeMemics Biotechnologies Executive Officer & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

HeMemics Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeMemics Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
American Vietnamese Investment Partners Venture Capital Minority 000 0000 000000 0
Inova Strategic Investments Corporate Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maryland Industrial Partnerships Other Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
To view HeMemics Biotechnologies’s complete investors history, request access »